nodes	percent_of_prediction	percent_of_DWPC	metapath
Equilin—HSD17B1—Diseases associated with visual transduction—SDC4—lung cancer	0.0553	0.0607	CbGpPWpGaD
Equilin—HSD17B1—Diseases associated with visual transduction—AKR1C1—lung cancer	0.0415	0.0455	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of steroid hormones and vitamin D—POMC—lung cancer	0.0348	0.0382	CbGpPWpGaD
Equilin—SHBG—Nongenotropic Androgen signaling—MAP2K1—lung cancer	0.0247	0.0271	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—COL4A3BP—lung cancer	0.0246	0.027	CbGpPWpGaD
Equilin—SHBG—Nongenotropic Androgen signaling—RAF1—lung cancer	0.0219	0.0241	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—PLBD1—lung cancer	0.0187	0.0205	CbGpPWpGaD
Equilin—HSD17B1—Diseases associated with visual transduction—APOA1—lung cancer	0.0172	0.0189	CbGpPWpGaD
Equilin—SHBG—Nongenotropic Androgen signaling—SRC—lung cancer	0.0172	0.0188	CbGpPWpGaD
Equilin—SHBG—Nongenotropic Androgen signaling—MAPK3—lung cancer	0.0158	0.0174	CbGpPWpGaD
Equilin—Conjugated Estrogens—ABCC3—lung cancer	0.015	0.168	CrCbGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—MTMR3—lung cancer	0.0145	0.0159	CbGpPWpGaD
Equilin—SHBG—Nongenotropic Androgen signaling—PIK3CA—lung cancer	0.013	0.0143	CbGpPWpGaD
Equilin—SHBG—Nongenotropic Androgen signaling—HRAS—lung cancer	0.0121	0.0133	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—AZIN2—lung cancer	0.011	0.012	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—COL4A3BP—lung cancer	0.011	0.012	CbGpPWpGaD
Equilin—SHBG—Nongenotropic Androgen signaling—AKT1—lung cancer	0.0107	0.0117	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—ABCC3—lung cancer	0.0102	0.0112	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—AKR1C1—lung cancer	0.0099	0.0109	CbGpPWpGaD
Equilin—Estradiol—UGT1A1—lung cancer	0.00977	0.109	CrCbGaD
Equilin—HSD17B1—Metabolism—ATP5H—lung cancer	0.00932	0.0102	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	0.00857	0.00941	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PLBD1—lung cancer	0.00831	0.00912	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	0.00817	0.00897	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—HSD17B10—lung cancer	0.0076	0.00834	CbGpPWpGaD
Equilin—HSD17B1—Disease—PGAM1—lung cancer	0.00752	0.00826	CbGpPWpGaD
Equilin—Conjugated Estrogens—ABCG2—lung cancer	0.00727	0.0814	CrCbGaD
Equilin—Estrone—ABCG2—lung cancer	0.00725	0.0812	CrCbGaD
Equilin—HSD17B1—Metabolism—CKB—lung cancer	0.00706	0.00776	CbGpPWpGaD
Equilin—HSD17B1—Disease—SDC4—lung cancer	0.00702	0.00771	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—AXL—lung cancer	0.00695	0.00763	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—CNDP2—lung cancer	0.00664	0.00729	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—GSTM2—lung cancer	0.00664	0.00729	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—MTMR3—lung cancer	0.00646	0.00709	CbGpPWpGaD
Equilin—Estriol—ABCB1—lung cancer	0.00634	0.071	CrCbGaD
Equilin—HSD17B1—Metabolism—PGAM1—lung cancer	0.0063	0.00691	CbGpPWpGaD
Equilin—HSD17B1—Disease—SKI—lung cancer	0.00619	0.0068	CbGpPWpGaD
Equilin—HSD17B1—Disease—B4GALT5—lung cancer	0.00601	0.0066	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—CYP2A7—lung cancer	0.00601	0.0066	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—SDC4—lung cancer	0.00588	0.00645	CbGpPWpGaD
Equilin—Estrone—CYP2E1—lung cancer	0.00575	0.0645	CrCbGaD
Equilin—Estrone—CYP1A1—lung cancer	0.00568	0.0636	CrCbGaD
Equilin—Estradiol—ABCG2—lung cancer	0.00549	0.0615	CrCbGaD
Equilin—HSD17B1—Signaling Pathways—COL4A2—lung cancer	0.0054	0.00593	CbGpPWpGaD
Equilin—HSD17B1—Disease—PXN—lung cancer	0.00538	0.0059	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—RRM1—lung cancer	0.00535	0.00588	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—GSTA3—lung cancer	0.00535	0.00588	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—GIPR—lung cancer	0.00527	0.00578	CbGpPWpGaD
Equilin—HSD17B1—Disease—AKR1C1—lung cancer	0.00526	0.00578	CbGpPWpGaD
Equilin—Estropipate—ALB—lung cancer	0.00508	0.0569	CrCbGaD
Equilin—HSD17B1—Metabolism—B4GALT5—lung cancer	0.00503	0.00553	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—SDC4—lung cancer	0.00492	0.0054	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—GSTA4—lung cancer	0.0049	0.00538	CbGpPWpGaD
Equilin—HSD17B1—Disease—NPPA—lung cancer	0.00485	0.00532	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—DUSP3—lung cancer	0.00482	0.00529	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	0.00479	0.00526	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—GSTA2—lung cancer	0.00477	0.00524	CbGpPWpGaD
Equilin—HSD17B1—Disease—PPIA—lung cancer	0.00473	0.00519	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—RHEB—lung cancer	0.00472	0.00519	CbGpPWpGaD
Equilin—HSD17B1—Disease—ALDOA—lung cancer	0.00469	0.00515	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—GSTA1—lung cancer	0.0046	0.00506	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—ABCC3—lung cancer	0.00455	0.005	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—GRM8—lung cancer	0.00448	0.00492	CbGpPWpGaD
Equilin—HSD17B1—Disease—ADCY1—lung cancer	0.00443	0.00487	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—AKR1C1—lung cancer	0.00441	0.00484	CbGpPWpGaD
Equilin—HSD17B1—Disease—ENO2—lung cancer	0.00435	0.00477	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—SKI—lung cancer	0.00434	0.00476	CbGpPWpGaD
Equilin—HSD17B1—Disease—SMARCA4—lung cancer	0.00432	0.00474	CbGpPWpGaD
Equilin—HSD17B1—Disease—PPP2R1B—lung cancer	0.00432	0.00474	CbGpPWpGaD
Equilin—Estradiol—CYP1A1—lung cancer	0.0043	0.0482	CrCbGaD
Equilin—HSD17B1—Metabolism—UGT1A1—lung cancer	0.00428	0.0047	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—GNG11—lung cancer	0.00413	0.00453	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—APOA1—lung cancer	0.00411	0.00451	CbGpPWpGaD
Equilin—HSD17B1—Disease—ENO1—lung cancer	0.00395	0.00434	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—ALDOA—lung cancer	0.00393	0.00431	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—NCOA3—lung cancer	0.00381	0.00419	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PXN—lung cancer	0.00377	0.00413	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	0.00375	0.00412	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—ADCY1—lung cancer	0.00371	0.00407	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—ABCG2—lung cancer	0.00371	0.00407	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—AKR1C1—lung cancer	0.00369	0.00405	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—GRP—lung cancer	0.00369	0.00405	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—OXTR—lung cancer	0.00369	0.00405	CbGpPWpGaD
Equilin—HSD17B1—Disease—APP—lung cancer	0.00367	0.00403	CbGpPWpGaD
Equilin—HSD17B1—Disease—FGF9—lung cancer	0.00364	0.004	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—HPGDS—lung cancer	0.00364	0.004	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—ENO2—lung cancer	0.00364	0.004	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PPP2R1B—lung cancer	0.00362	0.00397	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—POMC—lung cancer	0.00357	0.00392	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—GSTT1—lung cancer	0.00353	0.00388	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—GCLC—lung cancer	0.00349	0.00383	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—CYP2A6—lung cancer	0.00349	0.00383	CbGpPWpGaD
Equilin—HSD17B1—Disease—JUNB—lung cancer	0.00348	0.00382	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	0.00348	0.00382	CbGpPWpGaD
Equilin—Ethinyl Estradiol—ABCB1—lung cancer	0.00346	0.0388	CrCbGaD
Equilin—HSD17B1—Signaling Pathways—GNG11—lung cancer	0.00345	0.00379	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—ENO1—lung cancer	0.00331	0.00363	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	0.0033	0.00362	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—VEGFC—lung cancer	0.00329	0.00361	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—ALB—lung cancer	0.00325	0.00357	CbGpPWpGaD
Equilin—Estrone—ALB—lung cancer	0.00316	0.0354	CrCbGaD
Equilin—HSD17B1—Signaling Pathways—ADCY1—lung cancer	0.0031	0.00341	CbGpPWpGaD
Equilin—HSD17B1—Disease—FOXO3—lung cancer	0.00305	0.00335	CbGpPWpGaD
Equilin—Conjugated Estrogens—ABCB1—lung cancer	0.00302	0.0339	CrCbGaD
Equilin—HSD17B1—Signaling Pathways—PPP2R1B—lung cancer	0.00302	0.00332	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—SMARCA4—lung cancer	0.00302	0.00332	CbGpPWpGaD
Equilin—Estrone—ABCB1—lung cancer	0.00302	0.0338	CrCbGaD
Equilin—HSD17B1—Metabolism—CYP2E1—lung cancer	0.00297	0.00326	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—NQO1—lung cancer	0.00293	0.00322	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—HSPB1—lung cancer	0.00292	0.0032	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PTHLH—lung cancer	0.00288	0.00317	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	0.00287	0.00315	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	0.00285	0.00313	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—ANXA1—lung cancer	0.00271	0.00298	CbGpPWpGaD
Equilin—HSD17B1—Disease—HES1—lung cancer	0.0027	0.00296	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—STK11—lung cancer	0.00264	0.0029	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—FLT1—lung cancer	0.00263	0.00288	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—NOTCH3—lung cancer	0.00257	0.00282	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—APP—lung cancer	0.00257	0.00282	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—FGF9—lung cancer	0.00255	0.0028	CbGpPWpGaD
Equilin—HSD17B1—Disease—ERCC2—lung cancer	0.00252	0.00277	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—PTEN—lung cancer	0.00248	0.00273	CbGpPWpGaD
Equilin—HSD17B1—Disease—ERBB3—lung cancer	0.00247	0.00271	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—GSTP1—lung cancer	0.00245	0.00269	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—JUNB—lung cancer	0.00244	0.00267	CbGpPWpGaD
Equilin—Estradiol—ALB—lung cancer	0.0024	0.0268	CrCbGaD
Equilin—HSD17B1—Metabolism—CAT—lung cancer	0.00238	0.00261	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—EP300—lung cancer	0.00237	0.0026	CbGpPWpGaD
Equilin—HSD17B1—Disease—TERT—lung cancer	0.00237	0.0026	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—ABCB1—lung cancer	0.00232	0.00254	CbGpPWpGaD
Equilin—HSD17B1—Disease—FGFR1—lung cancer	0.0023	0.00252	CbGpPWpGaD
Equilin—Estradiol—ABCB1—lung cancer	0.00229	0.0256	CrCbGaD
Equilin—HSD17B1—Metabolism—TYMS—lung cancer	0.00227	0.0025	CbGpPWpGaD
Equilin—HSD17B1—Disease—HIF1A—lung cancer	0.00226	0.00248	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—GSTM1—lung cancer	0.00225	0.00247	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—STK11—lung cancer	0.00221	0.00243	CbGpPWpGaD
Equilin—HSD17B1—Disease—APOA1—lung cancer	0.00218	0.0024	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—FOXO3—lung cancer	0.00213	0.00234	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—CYP1A1—lung cancer	0.00213	0.00234	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—ERCC2—lung cancer	0.00211	0.00232	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—AVP—lung cancer	0.002	0.0022	CbGpPWpGaD
Equilin—HSD17B1—Disease—KIT—lung cancer	0.00199	0.00219	CbGpPWpGaD
Equilin—HSD17B1—Disease—APC—lung cancer	0.00199	0.00219	CbGpPWpGaD
Equilin—HSD17B1—Disease—EGF—lung cancer	0.00197	0.00216	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—IGF1R—lung cancer	0.00192	0.00211	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—HES1—lung cancer	0.00189	0.00208	CbGpPWpGaD
Equilin—HSD17B1—Disease—BRAF—lung cancer	0.00187	0.00206	CbGpPWpGaD
Equilin—HSD17B1—Disease—IL6R—lung cancer	0.00185	0.00203	CbGpPWpGaD
Equilin—HSD17B1—Disease—CREBBP—lung cancer	0.00185	0.00203	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—APOA1—lung cancer	0.00183	0.00201	CbGpPWpGaD
Equilin—HSD17B1—Disease—MAP2K1—lung cancer	0.00176	0.00194	CbGpPWpGaD
Equilin—HSD17B1—Disease—PIK3CD—lung cancer	0.00175	0.00192	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	0.00175	0.00192	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—ERBB3—lung cancer	0.00173	0.0019	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PIK3CG—lung cancer	0.00167	0.00183	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—TERT—lung cancer	0.00166	0.00182	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—FGFR1—lung cancer	0.00161	0.00177	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—POMC—lung cancer	0.00159	0.00174	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—HIF1A—lung cancer	0.00158	0.00174	CbGpPWpGaD
Equilin—HSD17B1—Disease—MDM2—lung cancer	0.00157	0.00172	CbGpPWpGaD
Equilin—HSD17B1—Disease—RAF1—lung cancer	0.00156	0.00172	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—CREBBP—lung cancer	0.00155	0.0017	CbGpPWpGaD
Equilin—HSD17B1—Disease—ERBB2—lung cancer	0.00155	0.0017	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—APOA1—lung cancer	0.00153	0.00168	CbGpPWpGaD
Equilin—HSD17B1—Disease—MTOR—lung cancer	0.00153	0.00168	CbGpPWpGaD
Equilin—HSD17B1—Disease—PIK3CB—lung cancer	0.00153	0.00168	CbGpPWpGaD
Equilin—HSD17B1—Disease—CD4—lung cancer	0.00152	0.00167	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—KDR—lung cancer	0.00152	0.00166	CbGpPWpGaD
Equilin—HSD17B1—Disease—PTGS2—lung cancer	0.00151	0.00166	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PIK3CD—lung cancer	0.00147	0.00161	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—ALB—lung cancer	0.00145	0.00159	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—APC—lung cancer	0.0014	0.00153	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PIK3CG—lung cancer	0.0014	0.00153	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—KIT—lung cancer	0.0014	0.00153	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—EGF—lung cancer	0.00138	0.00152	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—POMC—lung cancer	0.00133	0.00146	CbGpPWpGaD
Equilin—HSD17B1—Disease—CDKN1A—lung cancer	0.00132	0.00145	CbGpPWpGaD
Equilin—HSD17B1—Disease—PTEN—lung cancer	0.00132	0.00145	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—BRAF—lung cancer	0.00131	0.00144	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—IL6R—lung cancer	0.0013	0.00142	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CREBBP—lung cancer	0.00129	0.00142	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PIK3CB—lung cancer	0.00128	0.0014	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PTGS2—lung cancer	0.00127	0.00139	CbGpPWpGaD
Equilin—HSD17B1—Disease—EP300—lung cancer	0.00126	0.00138	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—MAP2K1—lung cancer	0.00124	0.00136	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PIK3CD—lung cancer	0.00123	0.00135	CbGpPWpGaD
Equilin—HSD17B1—Disease—SRC—lung cancer	0.00122	0.00134	CbGpPWpGaD
Equilin—HSD17B1—Disease—STAT3—lung cancer	0.00118	0.0013	CbGpPWpGaD
Equilin—HSD17B1—Disease—NRAS—lung cancer	0.00118	0.00129	CbGpPWpGaD
Equilin—HSD17B1—Disease—MAPK3—lung cancer	0.00113	0.00124	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PTEN—lung cancer	0.00111	0.00121	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—MDM2—lung cancer	0.0011	0.00121	CbGpPWpGaD
Equilin—HSD17B1—Disease—MYC—lung cancer	0.0011	0.0012	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—RAF1—lung cancer	0.0011	0.0012	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—ERBB2—lung cancer	0.00108	0.00119	CbGpPWpGaD
Equilin—HSD17B1—Disease—EGFR—lung cancer	0.00107	0.00118	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—MTOR—lung cancer	0.00107	0.00117	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PIK3CB—lung cancer	0.00107	0.00117	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—EP300—lung cancer	0.00105	0.00116	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CXCL8—lung cancer	0.00103	0.00113	CbGpPWpGaD
Equilin—HSD17B1—Disease—KRAS—lung cancer	0.00101	0.00111	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CASP3—lung cancer	0.000984	0.00108	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—IL2—lung cancer	0.000982	0.00108	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CCND1—lung cancer	0.000958	0.00105	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—JUN—lung cancer	0.000956	0.00105	CbGpPWpGaD
Equilin—HSD17B1—Disease—PIK3CA—lung cancer	0.000931	0.00102	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—MMP9—lung cancer	0.00093	0.00102	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CDKN1A—lung cancer	0.000926	0.00102	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PTEN—lung cancer	0.000924	0.00101	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—EP300—lung cancer	0.000882	0.000968	CbGpPWpGaD
Equilin—HSD17B1—Disease—HRAS—lung cancer	0.000862	0.000946	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—SRC—lung cancer	0.000857	0.000941	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—VEGFA—lung cancer	0.000835	0.000917	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—STAT3—lung cancer	0.000827	0.000908	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—NRAS—lung cancer	0.000825	0.000905	CbGpPWpGaD
Equilin—HSD17B1—Disease—IL6—lung cancer	0.000825	0.000905	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—MAPK3—lung cancer	0.00079	0.000867	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PIK3CA—lung cancer	0.00078	0.000856	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—MYC—lung cancer	0.000768	0.000843	CbGpPWpGaD
Equilin—HSD17B1—Disease—AKT1—lung cancer	0.000761	0.000835	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—EGFR—lung cancer	0.000751	0.000825	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—KRAS—lung cancer	0.00071	0.000779	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PIK3CA—lung cancer	0.000652	0.000716	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—AKT1—lung cancer	0.000637	0.000699	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—TP53—lung cancer	0.000631	0.000693	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—HRAS—lung cancer	0.000603	0.000662	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—IL6—lung cancer	0.000577	0.000634	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—AKT1—lung cancer	0.000533	0.000585	CbGpPWpGaD
